PharmaBoardroom

The US heads for three leading international mid-cap innovators – Japanese firms Eisai and Kyowa Kirin and Danish outfit Lundbeck – explain their…

Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park looks at how a technology developed in Japan over a decade ago is poised to drive…

A roundup of the latest from the Middle East & Africa region, including Turkey’s debt to US pharma; deals between Saudi SPIMACO and Janssen, Abu…

The collaboration between BioNTech and Pfizer on a COVID-19 vaccine candidate based on mRNA technology continues apace, with hopes for an emergency…

German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant Pfizer on a COVID-19 vaccine. The…

BMS Norway’s Hilde Bech outlines her hopes of bringing "the medicines of the future" to Norwegian patients, why tiny Norway still has global…

UNICEF’s Eva Kadilli outlines the work that the organisation’s supply division is undertaking in the global push for a COVID-19 vaccine, the…

Intergenerika’s Dr Axel B. Müller makes an impassioned case against the introduction of a reference pricing system in Switzerland, arguing that it…

Biogen Switzerland’s Dr Katharina Gasser outlines how the company’s 100 percent commitment to neuroscience helps it to stand apart, why…

The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of Pedro Facon, director general for…

Every year, Polish news magazine Wprost publishes its ranking of the top 200 Polish companies across all industries. Here, we profile the top five…

Ahead of the 2020 US National Organization for Rare Disorders (NORD)’s Rare Diseases and Orphan Products Breakthrough Summit, NORD president and CEO…